| Dr Tzvi Bluestone, MD | |
|
14 Prospect St, Milford, MA 01757-3003 | |
| (508) 473-1190 | |
| (508) 236-7909 |
| Full Name | Dr Tzvi Bluestone |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 20 Years |
| Location | 14 Prospect St, Milford, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891981734 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | ME99933 (Florida) | Secondary |
| 207R00000X | Internal Medicine | 246088 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Milford Regional Medical Center | Milford, MA | Hospital |
| Brigham And Women's Hospital | Boston, MA | Hospital |
| Entity Name | Prima Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265422596 PECOS PAC ID: 2567356017 Enrollment ID: O20040214000027 |
News Archive
Researchers say that the Quality and Outcomes Framework that was introduced to UK general practice in 2004 may not be worth the expense of implementing it in terms of benefiting patients.
Social media has become a platform for new mothers to openly share their experiences of the joys and challenges of parenthood.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Researchers from the Miami University in Ohio have optimized a new technique that will allow scientists to evaluate how potential inhibitors work on antibiotic-resistant bacteria.
› Verified 7 days ago
| Entity Name | Milford Regional Physician Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902856024 PECOS PAC ID: 5597679449 Enrollment ID: O20040503001341 |
News Archive
Researchers say that the Quality and Outcomes Framework that was introduced to UK general practice in 2004 may not be worth the expense of implementing it in terms of benefiting patients.
Social media has become a platform for new mothers to openly share their experiences of the joys and challenges of parenthood.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Researchers from the Miami University in Ohio have optimized a new technique that will allow scientists to evaluate how potential inhibitors work on antibiotic-resistant bacteria.
› Verified 7 days ago
| Entity Name | Sturdy Memorial Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063866176 PECOS PAC ID: 9537152806 Enrollment ID: O20160811001583 |
News Archive
Researchers say that the Quality and Outcomes Framework that was introduced to UK general practice in 2004 may not be worth the expense of implementing it in terms of benefiting patients.
Social media has become a platform for new mothers to openly share their experiences of the joys and challenges of parenthood.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Researchers from the Miami University in Ohio have optimized a new technique that will allow scientists to evaluate how potential inhibitors work on antibiotic-resistant bacteria.
› Verified 7 days ago
| Entity Name | Sharon Direct Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053064535 PECOS PAC ID: 5092109108 Enrollment ID: O20220304001896 |
News Archive
Researchers say that the Quality and Outcomes Framework that was introduced to UK general practice in 2004 may not be worth the expense of implementing it in terms of benefiting patients.
Social media has become a platform for new mothers to openly share their experiences of the joys and challenges of parenthood.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Researchers from the Miami University in Ohio have optimized a new technique that will allow scientists to evaluate how potential inhibitors work on antibiotic-resistant bacteria.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tzvi Bluestone, MD 12a Billings St, Sharon, MA 02067-2120 Ph: (708) 806-0467 | Dr Tzvi Bluestone, MD 14 Prospect St, Milford, MA 01757-3003 Ph: (508) 473-1190 |
News Archive
Researchers say that the Quality and Outcomes Framework that was introduced to UK general practice in 2004 may not be worth the expense of implementing it in terms of benefiting patients.
Social media has become a platform for new mothers to openly share their experiences of the joys and challenges of parenthood.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Researchers from the Miami University in Ohio have optimized a new technique that will allow scientists to evaluate how potential inhibitors work on antibiotic-resistant bacteria.
› Verified 7 days ago
Dr. Seth Wakefield, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 14 Prospect St, Milford, MA 01757 Phone: 508-473-1190 | |
Mona S Kaddis, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 14 Prospect St, 2nd Floor, Milford, MA 01757 Phone: 508-478-2061 | |
Dr. Harold R Moore, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 213 West St, Ste 1, Milford, MA 01757 Phone: 508-478-5372 Fax: 508-478-5374 | |
Hasina Hamid, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 221 E Main St, Milford, MA 01757 Phone: 508-473-7599 Fax: 508-541-2420 | |
Anita Koshy, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 20 Prospect St, Milford, MA 01757 Phone: 508-488-3700 | |
Dr. Ajay K Batra, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 215 West St, Milford, MA 01757 Phone: 508-478-6363 Fax: 508-478-0349 | |
Dr. Philip Daniel Messer, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 14 Prospect St, Milford, MA 01757 Phone: 508-473-1190 |